Perry Ellis International Announces Boy's Tailored Clothing License for Perry Ellis Brand
Nov 08, 2016 14:30 pm UTC| Business
MIAMI, Nov. 08, 2016 -- Perry Ellis International (Nasdaq:PERY) announced today that it has entered into a license agreement with Peerless Clothing International for boy's tailored clothing, namely suits, sport coats,...
Nov 08, 2016 14:30 pm UTC| Business
SAN FRANCISCO, Nov. 08, 2016 -- Hagens Berman Sobol Shapiro LLP reminds investors in Spectrum Pharmaceuticals Inc. (NASDAQ:SPPI) of the securities class action lawsuit and November 21, 2016 Lead Plaintiff deadline. If...
Syndax Pharmaceuticals to Present at the SITC 31st Annual Scientific Meeting
Nov 08, 2016 14:27 pm UTC| Business
WALTHAM, Mass., Nov. 08, 2016 -- Syndax Pharmaceuticals, Inc. ("Syndax," the "Company" or "we") (Nasdaq:SNDX), a clinical stage biopharmaceutical company focused on developing entinostat and SNDX-6352 in multiple cancer...
Nov 08, 2016 14:27 pm UTC| Business
NEW YORK, Nov. 08, 2016 -- Prospect Capital Corporation (NASDAQ:PSEC) (“Prospect”) announced today that Prospect’s portfolio company National Property REIT Corp. (“NPRC”) recently sold its Abbington Pointe (“Abbington”)...
Melco Crown Entertainment Announces New Leadership Structure
Nov 08, 2016 14:14 pm UTC| Business
MACAU, Nov. 08, 2016 -- Melco Crown Entertainment Limited (Nasdaq:MPEL) (“Melco Crown Entertainment” or the “Company” or “we”), a developer, owner and operator of casino gaming and entertainment casino resort facilities...
Nov 08, 2016 14:10 pm UTC| Business
Preliminary Phase 1/2 Efficacy Data of Lirilumab in Combination with Opdivo (Nivolumab) in Patients With Advanced Platinum Refractory Squamous Cell Carcinoma of the Head and Neck to be presented during SITC meeting ...
New XOMA Antibodies Unveiled at The Society for Immunotherapy of Cancer 31st Annual Meeting
Nov 08, 2016 14:01 pm UTC| Business
Preclinical Data from XOMA’s Novel Anti-IL-2 Immuno-oncology Monoclonal Antibodies Program to be Presented at SITCAdvancing Unique Functional Antibody Antagonists Targeting the Parathyroid Hormone Receptor 1 (PTH1R)Plan to...